{"id":19143,"date":"2021-03-30T18:13:25","date_gmt":"2021-03-30T18:13:25","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=19143"},"modified":"2021-03-30T18:13:29","modified_gmt":"2021-03-30T18:13:29","slug":"evento-vacina-covid-06-04","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/evento-vacina-covid-06-04\/","title":{"rendered":"Evento Educacional Vacina COVID-19 Oxford\/AstraZeneca\/Fiocruz"},"content":{"rendered":"<p style=\"text-align: justify;\">Na ter\u00e7a-feira (06\/04\/2021), a AstraZeneca, a Oxford e a Fiocruz realizar\u00e3o um evento sobre a vacina\u00e7\u00e3o contra a COVID-19.<\/p>\n<p style=\"text-align: justify;\">A programa\u00e7\u00e3o vai abordar a tecnologia da vacina ChAdOx1, dados de efic\u00e1cia na popula\u00e7\u00e3o de risco e o que esperar no futuro.<\/p>\n<p>Veja a programa\u00e7\u00e3o completa e inscreva-se:<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/vacinaumfuturoparatodos.com.br\/\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" class=\"aligncenter wp-image-19144 size-large\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/03\/az-vacina-covid-797x1024.jpg\" alt=\"\" width=\"640\" height=\"822\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/03\/az-vacina-covid-797x1024.jpg 797w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/03\/az-vacina-covid-233x300.jpg 233w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/03\/az-vacina-covid-768x987.jpg 768w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<h5>Popula\u00e7\u00e3o de risco<\/h5>\n<p style=\"text-align: justify;\">Os dados epidemiol\u00f3gicos indicam que entre 20% a 30% dos pacientes que s\u00e3o positivos para SARS-CoV-2 desenvolvem sintomas significativos o suficiente para exigir hospitaliza\u00e7\u00e3o. Destes, cerca de um ter\u00e7o pode precisar cuidados intensivos.<\/p>\n<p style=\"text-align: justify;\">Idade avan\u00e7ada, presen\u00e7a de doen\u00e7a cardiovascular (incluindo IC) e DRC, bem como hipertens\u00e3o e diabetes, s\u00e3o alguns dos principais fatores de risco para sintomas mais graves e piores resultados, incluindo morte e fal\u00eancia de m\u00faltiplos \u00f3rg\u00e3os.<\/p>\n<p style=\"text-align: justify;\">Participe! Est\u00e1 nas nossas m\u00e3os fazer a diferen\u00e7a nesse momento t\u00e3o delicado da pandemia da COVID-19. <a href=\"https:\/\/vacinaumfuturoparatodos.com.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">Inscreva-se aqui<\/a>.<\/p>\n<p>Informa\u00e7\u00f5es: AstraZeneca.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Na ter\u00e7a-feira (06\/04\/2021), a AstraZeneca, a Oxford e a Fiocruz realizar\u00e3o um evento sobre a vacina\u00e7\u00e3o contra a COVID-19. A programa\u00e7\u00e3o vai abordar a tecnologia da vacina ChAdOx1, dados de efic\u00e1cia na popula\u00e7\u00e3o de risco e o que esperar no futuro. Veja a programa\u00e7\u00e3o completa e inscreva-se: Popula\u00e7\u00e3o de risco&#8230;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":7,"featured_media":19145,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[37],"tags":[1133],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2025-07-17 06:54:17","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/19143"}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=19143"}],"version-history":[{"count":1,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/19143\/revisions"}],"predecessor-version":[{"id":19146,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/19143\/revisions\/19146"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/19145"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=19143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=19143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=19143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}